Lipids explained: screening to treatment
Intended for healthcare professionals
CPD Previous    

Lipids explained: screening to treatment

Rhiannon Edwards British Heart Foundation familial hypercholesterolaemia clinical specialist nurse, Royal Gwent Hospital, Newport

One of the risk factors for cardiovascular disease commonly seen in primary care is raised cholesterol. People are becoming more aware of the implications of lipid-lowering treatments, and are questioning the balance of treatment risk versus cardiovascular risk. At a time when prevention is becoming a priority in health care, it is increasingly important for patients to be counselled about cholesterol and future risk before lipid lowering therapy, to ensure compliance. This article aims to provide all the necessary information for primary health care professionals to feel competent in these discussions.

Primary Health Care. 23, 1, 32-38. doi: 10.7748/phc2013.02.23.1.32.e774

Correspondence

rhiannon.edwards6@wales.nhs.uk

Conflict of interest

None declared

Peer review

This article has been subject to double blind peer review

Received: 18 June 2012

Accepted: 23 October 2012

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more